FDA Investigator Dung N Tran
Dung N Tran has conducted inspections on 55 sites in 1 countries as of 22 Jun 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
55
Last Inspection Date:
22 Jun 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Dung N Tran:
Ali Akbar,
Amber G Chung,
Andrea L Williams Jones,
Andrew J Howard,
Angela L Hatzenbuhler,
Ashley L Reiber,
Ashley M Whitehurst,
Austin B Appler,
Barbara J Holladay,
Brandi L Garbutt,
Brandon J Brookens,
Brandon L Mariner,
Cassandra K Johnson,
CDR Michael J Mero,
Charles E Idjagboro,
Christina N Maurino,
Christopher L Taste,
Christopher R Richardson,
Clarice J Ahn,
Collins M Mason,
Craig W Swanson,
Daniel R Azar,
David H Smith,
David L Chon,
David P Rice, Jr,
Deshonna L Mitchell,
Dessa A Antoine,
Dhaval H Patel,
Earl Echon,
Edette J Newby,
Edward P Potter,
Elvis D Morton,
Emmanuel A Dimaano, Jr,
Erin L Mcfiren,
Esaw,
Gale L Glinecki,
Gerald W Kopp,
Gianine E Delade,
Heath R Harley,
Hector Jcolon Torres,
Helen B Ricalde,
Holly S Simms,
Jacqueline Johnson,
Jacquelyn D Hokamp,
Jamie D Swann,
Jananiga Vanniyasingam,
Jason Kwong,
Jason M Sluzynski,
Jeffrey A Reed,
Jennifer L Barre,
Jessica D Nanini,
Jessica D Weber,
Jessica K Yoon,
John Dan,
Johnson,
Joseph Duca,
Joseph L Despins, PhD,
Joseph W Matthews,
Julie A Silberberg,
Julie M Anbarchian,
Justin A Hefferman,
Justin C Fuller,
Karen A Spencer,
Kelly Dragon,
Kenneth Nieves,
Laishan L Lam,
Laurianne M Montonye,
Laurissa S Flowers,
Lawrence R Johnson,
LCDR Cornelius Brown, III,
Li Li,
Linda J Eason,
Lisa R Heath,
LTJG Bradley E Benasutti,
LTJG Lauren N Shade,
Marc A Jackson, Jr,
Margaret H Waters,
Michael A Taylor,
Michael D Omeara,
Michael L Zimmerman,
Miguel Gmanzano Maldonado,
Mildred L Mccray,
Mohamad A Chahine,
Monique Rac Lester,
Myra L Gemmill,
Myra L Reed,
Nancy L Meade,
Nash,
Natasha A Dezinna,
Nebil A Oumer,
Nicholas P Schaub,
Nina D Patel,
Osama M Hamoud,
Patricia A Morrow,
Patrick C Klotzbuecher,
Peter R Lenahan,
Philip W Beck,
Rachel C Harrington,
Regina Gibson Melton,
Remache,
Renisha M Shaw,
Rina Bhikha,
Schultz,
Sean D Duke,
Shelby W Brown, Jr,
Shusheen A Alexander,
Sinai I Davis,
Slatten,
Stephanie Mangigian, MS/OSH, RN,
Susan J Essenmacher,
Sylvia R Dooling,
Tamara N Champion,
Tammy M Phillips,
Tania E Vizcaino,
Tania K Mercado,
Teresa L Fox,
Theresa M Smedley,
Thomas N Adjabeng,
Thomas R Withers,
Timothy M Albright,
Todd J Maushart,
Upendra Paudel,
Vaishali J Patel,
Valeria A Moore,
Valerie C Reed,
Valerie G Vallely,
Wayne L Jefferson,
William A Warnick,
William D Murray
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more